[Preliminary findings on clinical and immunological effects of subcutaneously administered interleukin-2 + alpha-interferon combination in the treatment of advanced renal carcinoma]

MeSH terms

• Carcinoma, Renal Cell / immunology
• Carcinoma, Renal Cell / therapy*
• Female
• Humans
• Injections, Subcutaneous
• Interferon-alpha / administration & dosage*
• Interferon-alpha / toxicity
• Interleukin-2 / administration & dosage*
• Interleukin-2 / toxicity
• Kidney Neoplasms / immunology
• Kidney Neoplasms / therapy*
• Male
• Middle Aged
• Neoplasm Metastasis
• Time Factors